1 |
The index admission was an unplanned admission related to previous healthcare management |
H |
98.2 |
- |
|
100.0 |
- |
|
2 |
Length of index was over 30 days |
H |
100.0 |
- |
|
100.0 |
- |
|
3 |
Unplanned readmission after discharge from index admission1
|
H |
100.0 |
- |
|
100.0 |
- |
|
4 |
Revisiting emergency room within 72 hours after discharge from index admission |
G |
98.2 |
0.85 |
0.55, 1.00 |
96.3 |
0.65 |
0.19, 1.00 |
5 |
Unplanned transfer to another acute care hospital |
H |
100.0 |
1.00 |
|
100.0 |
1.00 |
|
6 |
Temperature higher than 38.3˚C at the point of discharge |
H |
100.0 |
- |
|
100.0 |
- |
|
7 |
Unplanned transfer from general care to intensive care1
|
H, G |
100.0 |
- |
|
100.0 |
- |
|
8 |
Speciality consult |
G |
88.9 |
0.19 |
-0.22, 0.61 |
92.6 |
0.67 |
0.37, 0.97 |
9 |
Cardiac or respiratory arrest, rapid response team activation1
|
H |
100.0 |
- |
|
100.0 |
- |
|
10 |
Unexpected death1
|
H, G |
100.0 |
- |
|
100.0 |
- |
|
11 |
Healthcare-associated infection |
H, G |
98.2 |
- |
|
100.0 |
- |
|
12 |
Hospital incurred patient injury1
|
H, G |
98.2 |
- |
|
100.0 |
- |
|
13 |
Over-sedation/hypotension |
G |
100.0 |
- |
|
100.0 |
- |
|
14 |
Restraint use1
|
G |
100.0 |
- |
|
100.0 |
- |
|
15 |
Acute dialysis1
|
G |
100.0 |
- |
|
100.0 |
- |
|
16 |
In-unit procedure |
G |
100.0 |
1.00 |
|
96.3 |
0.85 |
0.66, 1.00 |
17 |
Treatment for organ damage after an invasive procedure1
|
H |
100.0 |
- |
|
100.0 |
- |
|
18 |
Acute myocardial infarction, cerebrovascular accident, or pulmonary embolus during or after an invasive procedure1
|
H, G |
100.0 |
- |
|
100.0 |
- |
|
19 |
Transfusion or use of blood products |
G |
100.0 |
1.00 |
|
98.2 |
0.66 |
0.63, 1.00 |
20 |
Avil (pheniramine) or Benadryl (diphenhydramine) use by intramuscular or intravenous route |
G |
92.6 |
0.47 |
0.05, 0.89 |
98.2 |
0.90 |
0.70, 1.00 |
21 |
Abrupt medication stop |
G |
96.3 |
- |
|
96.3 |
0.73 |
0.38, 1.00 |
22 |
Antidotes use |
G |
98.2 |
0.66 |
0.03, 1.00 |
96.3 |
0.49 |
-0.11, 1.00 |
23 |
Adverse drug reaction |
H |
98.2 |
- |
|
100.0 |
1.00 |
|
24 |
Decrease in hemoglobin or hematocrit of 25% or greater |
G |
96.3 |
0.48 |
-0.13, 1.00 |
100.0 |
1.00 |
|
25 |
Hypoglycemic symptom |
G |
100.0 |
1.00 |
|
100.0 |
- |
|
26 |
Bleeding tendency |
G |
100.0 |
1.00 |
|
100.0 |
- |
|
27 |
Rising BUN or serum creatine greater than 2 times baseline |
G |
100.0 |
- |
|
100.0 |
- |
|
28 |
Clostridium difficile positive stool1
|
G |
100.0 |
- |
|
100.0 |
- |
|
29 |
Post-op troponin level greater than upper normal limit1
|
G |
100.0 |
- |
|
100.0 |
- |
|
30 |
Mechanical ventilation greater than 24 hours post-op1
|
G |
100.0 |
- |
|
100.0 |
- |
|
31 |
Unplanned return to the operating theatre1
|
H |
100.0 |
- |
|
100.0 |
- |
|
32 |
Unplanned removal, injury or repair of organ during surgery |
H |
100.0 |
- |
|
100.0 |
1.00 |
|
33 |
Intra-op epinephrine, norepinephrine, naloxone, or romazicon1
|
G |
100.0 |
- |
|
100.0 |
- |
|
34 |
Unplanned change in procedure or surgery1
|
H |
100.0 |
- |
|
100.0 |
- |
|
35 |
Intubation, reintubation, BiPap in post anesthesia care unit1
|
G |
100.0 |
- |
|
100.0 |
- |
|
36 |
X-ray in post anesthesia care unit1
|
G |
100.0 |
- |
|
100.0 |
- |
|
37 |
Terbutaline use in obstetrics |
G |
98.2 |
- |
|
100.0 |
- |
|
38 |
Oxytocic agents in obstetrics |
G |
100.0 |
1.00 |
|
100.0 |
1.00 |
|
39 |
Neonatal complications such as 5-minute Apgar score<6, or complication of abortion, amniocentesis or labor and delivery1
|
H, G |
100.0 |
- |
|
100.0 |
- |
|
40 |
Documentation or correspondence indicating litigation, dissatisfaction1
|
H |
100.0 |
- |
|
100.0 |
- |
|
41 |
Any other undesirable outcomes not covered above |
H |
96.3 |
-0.02 |
-0.05, 0.01 |
94.5 |
0.70 |
0.37, 1.00 |
|
Second-stage review necessity |
|
77.8 |
0.54 |
0.31, 0.77 |
83.3 |
0.67 |
0.47, 0.87 |